experimental group:CAR-T+X

2 trials

Sponsors

The Affiliated Hospital of Xuzhou Medical University

Conditions

B cell malignanciesB-cell tumor

Phase 1

Clinical study of CAR T cells combined with oncolytic adenovirus injection in the treatment of refractory B cell tumor with recurrent extramedullary mass

Active, not recruitingChiCTR2300075473

The Affiliated Hospital of Xuzhou Medical UniversityB-cell tumor

Start: 2023-10-01Updated: 2023-09-11

Phase 2

Clinical study of anti-CD19/CD20/CD22 CAR-T Cells+ X in the Treatment of Relapsed/Refractory B cell malignancies

RecruitingChiCTR2100049709

The Affiliated Hospital of Xuzhou Medical UniversityB cell malignancies

Start: 2021-08-05Updated: 2022-04-19